PYOTT DAVID E I bought TARS
April 24, 2026 · Form 4 insider transaction
PYOTT DAVID E I bought 1,383 shares of Tarsus Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,383
Price
N/A
Total value
N/A
InsiderPYOTT DAVID E I
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 24, 2026
Filing dateApril 28, 2026
Shares owned after1,383
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.